Literature DB >> 2154187

Molecular target sizes of inositol 1,4,5-trisphosphate receptors in liver and cerebellum.

D L Nunn1, B V Potter, C W Taylor.   

Abstract

Ins(1,4,5)P3 is the intracellular messenger that mediates the effects of many cell-surface receptors on intracellular Ca2+ stores. Although radioligand-binding studies have identified high-affinity Ins(1,4,5)P3-binding sites in many tissues, these have not yet been convincingly shown to be the receptors that mediate Ca2+ mobilization, nor is it clear whether there are differences in these binding sites between tissues. Here we report that Ins(1,4,5)P3 binds to a single class of high-affinity sites in both permeabilized hepatocytes (KD = 7.8 +/- 1.1 nM) and cerebellar membranes (KD = 6.5 +/- 2.4 nM), and provide evidence that these are unlikely to reflect binding to either of the enzymes known to metabolize Ins(1,4,5)P3. Furthermore, the rank order of potency of synthetic inositol phosphate analogues in displacing specifically bound Ins(1,4,5)P3 is the same as their rank order of potency in stimulating mobilization of intracellular Ca2+ stores, suggesting that the Ins(1,4,5)P3-binding site may be the physiological receptor. Radiation inactivation of the Ins(1,4,5)P3-binding sites of liver and cerebellum reveals that they have similar molecular target sizes: 257 +/- 36 kDa in liver and 258 +/- 20 kDa in cerebellum. We conclude that an Ins(1,4,5)P3-binding protein with a molecular target size of about 260 kDa is probably the receptor that mediates Ca2+ mobilization in hepatocytes, and our limited data provide no evidence to distinguish this from the cerebellar Ins(1,4,5)P3-binding protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154187      PMCID: PMC1136899          DOI: 10.1042/bj2650393

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  'Non-specific' binding. The problem, and a solution.

Authors:  C M Mendel; D B Mendel
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

3.  Inositol 1,4,5-trisphosphorothioate, a stable analogue of inositol trisphosphate which mobilizes intracellular calcium.

Authors:  C W Taylor; M J Berridge; A M Cooke; B V Potter
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

Review 4.  Size determination of enzymes by radiation inactivation.

Authors:  E S Kempner; W Schlegel
Journal:  Anal Biochem       Date:  1979-01-01       Impact factor: 3.365

5.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

6.  Size of acetylcholine receptors in the membrane. An improved version of the radiation inactivation method.

Authors:  M M Lo; E A Barnard; J O Dolly
Journal:  Biochemistry       Date:  1982-04-27       Impact factor: 3.162

7.  Inositol trisphosphate formation and calcium mobilization in Swiss 3T3 cells in response to platelet-derived growth factor.

Authors:  M J Berridge; J P Heslop; R F Irvine; K D Brown
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

8.  The inositol trisphosphate phosphomonoesterase of the human erythrocyte membrane.

Authors:  C P Downes; M C Mussat; R H Michell
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

Review 9.  Inositol trisphosphate, a novel second messenger in cellular signal transduction.

Authors:  M J Berridge; R F Irvine
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

10.  Myo-inositol(1,4,5)trisphosphorothioate binds to specific [3H]inositol(1,4,5)trisphosphate sites in rat cerebellum and is resistant to 5-phosphatase.

Authors:  A L Willcocks; B V Potter; A M Cooke; S R Nahorski
Journal:  Eur J Pharmacol       Date:  1988-10-11       Impact factor: 4.432

View more
  8 in total

1.  Purification and characterization of the inositol 1,4,5- trisphosphate receptor protein from rat vas deferens.

Authors:  R J Mourey; A Verma; S Supattapone; S H Snyder
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

2.  Increased expression of the inositol 1,4,5-trisphosphate receptor in human leukaemic (HL-60) cells differentiated with retinoic acid or dimethyl sulphoxide.

Authors:  P G Bradford; M Autieri
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

3.  The size of inositol 1,4,5-trisphosphate-sensitive Ca2+ stores depends on inositol 1,4,5-trisphosphate concentration.

Authors:  C W Taylor; B V Potter
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

4.  Synthesis and application of photoaffinity analogues of inositol 1,4,5-trisphosphate selectively substituted at the 1-phosphate group.

Authors:  R Schäfer; M Nehls-Sahabandu; B Grabowsky; M Dehlinger-Kremer; I Schulz; G W Mayr
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

5.  Liver inositol, 1,4,5-trisphosphate-binding sites are the Ca2(+)-mobilizing receptors.

Authors:  D L Nunn; C W Taylor
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

6.  The ligand binding site and transduction mechanism in the inositol-1,4,5-triphosphate receptor.

Authors:  G A Mignery; T C Südhof
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

7.  Subcellular distribution of the calcium-storing inositol 1,4,5-trisphosphate-sensitive organelle in rat liver. Possible linkage to the plasma membrane through the actin microfilaments.

Authors:  M F Rossier; G S Bird; J W Putney
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

8.  Identification and Characterization of High-Affinity Binding Sites for Inositol Trisphosphate in Red Beet.

Authors:  J. M. Brosnan; D. Sanders
Journal:  Plant Cell       Date:  1993-08       Impact factor: 11.277

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.